Co-Authors
This is a "connection" page, showing publications co-authored by Pierpaolo Di Micco and Federica Agrusta.
Connection Strength
0.513
-
Thromboprofilaxys With Fondaparinux vs. Enoxaparin in Hospitalized COVID-19 Patients: A Multicenter Italian Observational Study. Front Med (Lausanne). 2020; 7:569567.
Score: 0.229
-
Fondaparinux Use in Patients With COVID-19: A Preliminary Multicenter Real-World Experience. J Cardiovasc Pharmacol. 2020 10; 76(4):369-371.
Score: 0.226
-
Antithrombotic and Anti-Inflammatory Effects of Fondaparinux and Enoxaparin in Hospitalized COVID-19 Patients: The FONDENOXAVID Study. J Blood Med. 2021; 12:69-75.
Score: 0.058